PT1478662E - Método para o fabrico do alergeno principal do pólen de bétula hipoalergénico rbet v 1 - Google Patents

Método para o fabrico do alergeno principal do pólen de bétula hipoalergénico rbet v 1 Download PDF

Info

Publication number
PT1478662E
PT1478662E PT03706458T PT03706458T PT1478662E PT 1478662 E PT1478662 E PT 1478662E PT 03706458 T PT03706458 T PT 03706458T PT 03706458 T PT03706458 T PT 03706458T PT 1478662 E PT1478662 E PT 1478662E
Authority
PT
Portugal
Prior art keywords
birch pollen
pollen allergens
major birch
rbet
hypoallergenic major
Prior art date
Application number
PT03706458T
Other languages
English (en)
Inventor
Oliver Cromwell
Helmut Fiebig
Roland Suck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27763342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1478662(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PT1478662E publication Critical patent/PT1478662E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT03706458T 2002-02-27 2003-02-07 Método para o fabrico do alergeno principal do pólen de bétula hipoalergénico rbet v 1 PT1478662E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02004567 2002-02-27

Publications (1)

Publication Number Publication Date
PT1478662E true PT1478662E (pt) 2009-12-29

Family

ID=27763342

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03706458T PT1478662E (pt) 2002-02-27 2003-02-07 Método para o fabrico do alergeno principal do pólen de bétula hipoalergénico rbet v 1

Country Status (12)

Country Link
US (2) US20050123568A1 (pt)
EP (1) EP1478662B2 (pt)
JP (1) JP4343702B2 (pt)
AT (1) ATE443716T1 (pt)
AU (1) AU2003208817A1 (pt)
CA (1) CA2477409C (pt)
DE (1) DE50311945D1 (pt)
ES (1) ES2333951T5 (pt)
PL (1) PL206709B1 (pt)
PT (1) PT1478662E (pt)
RU (1) RU2311424C2 (pt)
WO (1) WO2003072601A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT503690A1 (de) 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
JP5279238B2 (ja) * 2006-11-16 2013-09-04 森川健康堂株式会社 血圧降下作用を有する花粉の製造方法
CA2786936A1 (en) * 2010-01-14 2011-07-21 Merck Patent Gmbh Variants of group 5 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues
EP2974741A1 (en) * 2014-07-16 2016-01-20 Stallergenes Composition of allergen extracts having reduced toxicity and method of production thereof
BR102017026619A2 (pt) 2017-02-15 2018-10-30 Euroimmun Medizinische Labordiagnostika Ag ensaio melhorado para a diagnose de alergia a amendoim
RU2761431C9 (ru) 2020-10-26 2022-04-18 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Рекомбинантный полипептид на основе аллергена пыльцы березы и аллергена яблока в качестве вакцины от аллергии

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10044360A1 (de) 2000-09-08 2002-03-21 Merck Patent Gmbh Verfahren zur Aufreinigung von rekombinanten als unlösliche Aggregate exprimierte Proteinen

Also Published As

Publication number Publication date
PL206709B1 (pl) 2010-09-30
ATE443716T1 (de) 2009-10-15
EP1478662B2 (de) 2017-07-05
DE50311945D1 (de) 2009-11-05
JP2005536454A (ja) 2005-12-02
PL373526A1 (en) 2005-09-05
US20090069236A1 (en) 2009-03-12
ES2333951T5 (es) 2017-11-16
EP1478662A1 (de) 2004-11-24
CA2477409A1 (en) 2003-09-04
AU2003208817A1 (en) 2003-09-09
US20050123568A1 (en) 2005-06-09
ES2333951T3 (es) 2010-03-03
RU2004129282A (ru) 2005-06-10
US9441021B2 (en) 2016-09-13
RU2311424C2 (ru) 2007-11-27
CA2477409C (en) 2015-01-27
JP4343702B2 (ja) 2009-10-14
EP1478662B1 (de) 2009-09-23
WO2003072601A8 (de) 2005-08-18
WO2003072601A1 (de) 2003-09-04

Similar Documents

Publication Publication Date Title
EP2298811B8 (en) Human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors
EP1585966A3 (en) METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES
MEP31508A (en) Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
HUP0600340A3 (en) Methods for identifying tumors that are responsive to treatment with anti-erbb2 antibodies
WO2004009590A8 (de) 4-aminosubstituierte pyrimidinderivate
WO2004106380A3 (en) Human-anti-human cd3 binding molecules
GB2386841B (en) Multi-channel bioresorbable nerve regeneration conduit and process for preparing the same
AU2003273171A1 (en) Immunomodulatory compounds and methods of use thereof
WO2004041258A3 (fr) Utilisation d’inhibiteurs des phosphodiesterases des nucleotides cycliques, ayant une structure benzodiazepinique en therapie
AU4754102A (en) Multi-channel bioresorbable nerve regeneration conduit and process for preparing the same
ATE306252T1 (de) Verfahren zur herstellung kristalliner partikel zur inhalation
EP1630227A4 (en) IMMOBILIZATION CARRIER, METHOD FOR THE PRODUCTION THEREOF, ELECTRODE, METHOD FOR THE PRODUCTION THEREOF, DEVICE USING THE ELECTRODE REACTION AND METHOD FOR THE PRODUCTION THEREOF
ME00226B (me) Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
EP1547579A4 (en) ADHESIVE GEL COMPOSITION FOR IONOPHORESIS PREPARATION AND PROCESS FOR PRODUCING THE SAME
PT1478662E (pt) Método para o fabrico do alergeno principal do pólen de bétula hipoalergénico rbet v 1
PL1817330T3 (pl) Pochodne alergenów białkowych
NZ524329A (en) IgE receptor antagonists that compete with IgE134 for binding to the receptor
MXPA06003381A (es) Beta aminoacidos terapeuticos.
AU2002365511A1 (en) Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23
EP1597234A4 (en) NEW COMPOUNDS
AU2002311623A1 (en) Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents
TW200700400A (en) Preparation of optically pure β-amino acids having affinity for the α-2-δ protein
WO2002057433A3 (de) Hipk-kinasen zur verwendung in der beeinflussung von zellteilung und zellproliferation
AU2003302616A1 (en) Process for preparing terbinafine by using platinum as catalyst
WO2001029193A3 (de) Zellkonstrukte, die für die immuntherapie geeignet sind, deren herstellung und verwendung